Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01719731 · ClinicalTrials.gov registry record · NA

Psychoeducation of Borderline Patients

A NA study, sponsored by Mclean Hospital.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT01719731: Completed NA study, sponsored by Mclean Hospital.

NCT01719731 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01719731, a NA study, has completed, sponsored by Mclean Hospital.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

Recent research suggests that BPD is a common, serious but treatable disorder with a better than previously recognized prognosis. Despite these findings, many patients with BPD are not given the borderline diagnosis by the mental health professionals treating them. It is also true that many newly diagnosed borderline patients are not provided with up-to-date information on the disorder even though psychoeducation has been found to be a useful form of treatment for other serious psychiatric illnesses. The investigators have conducted a preliminary randomized trial of psychoeducation for BPD that found that those provided with immediate psychoeducation had a significantly greater reduction in two core symptoms of BPD--general impulsivity and stormy relationships--than those with delayed psychoeducation. However, both instruction and assessment of change over time were conducted in person by paraprofessionals. The importance of the current study is that it will allow the investigators to develop and test the efficacy of an internet-based program of psychoeducation for BPD that will be both cost efficient and easy to disseminate widely, particularly to underserved populations.

Primary Outcome

A dimensional self-report measure of the nine DSM-IV symptoms of BPD

Interventions

  • BEHAVIORAL Education
  • BEHAVIORAL Non-Education

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-07
Est. Completion 2015-04
Phase NA
Mclean Hospital

140 total trials

What the finished NCT01719731 record still lists

NCT01719731 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.

NCT01719731 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01719731 about?

NCT01719731 is a clinical study titled "Psychoeducation of Borderline Patients". Recent research suggests that BPD is a common, serious but treatable disorder with a better than previously recognized prognosis. Despite these findings, many patients with BPD are not given the borderline diagnosis by the mental health professionals treating them. It is also true that many newly di...

What is the current status of trial NCT01719731?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-07. Estimated completion is 2015-04.

What interventions are being tested in trial NCT01719731?

The interventions under investigation include: Education (BEHAVIORAL), Non-Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT01719731?

This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01719731's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01719731, the US trial registry maintained by the National Library of Medicine. NCT01719731 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.